Indus Finance Limited — Quarter ended 31 March 2026 (Audited) and year ended 31 March 2026 (Audited)
The Audited standalone financial results are presented in lakhs.
| Sl No | Particulars | Quarter Ended 31.03.2026 (Audited) | Quarter Ended 31.12.2025 (Unaudited) | Quarter Ended 31.03.2025 (Audited) | Year Ended 31.03.2026 (Unaudited) | Year Ended 31.03.2025 (Audited) |
|---|---|---|---|---|---|---|
| 1 | Income from Operations | |||||
| (a) Interest Income | 64.56 | 122.34 | -1.86 | 400.02 | 339.51 | |
| (b) Dividend Income | 0.40 | 0.00 | 0.00 | 0.40 | 0.32 | |
| (c) Babt Debts Recovered | 0.00 | 0.00 | 0.00 | 0.10 | 0.00 | |
| (d) Net Gain on Fair Value Changes | 30.47 | 11.72 | 2.97 | 46.05 | 0.00 | |
| (e) Insurance Bonus | 473.92 | 0.00 | 0.00 | 473.92 | 0.00 | |
| (f) Profit on Sale of Investments | 0.00 | 2.91 | 100.80 | 2.91 | 208.05 | |
| (g) Other Income | 12.39 | 0.25 | 25.20 | 12.64 | 31.37 | |
| Total Income | 581.74 | 137.24 | 127.11 | 936.04 | 579.25 | |
| 2 | Expenses | |||||
| a) Finance Costs | 154.30 | 39.46 | 50.56 | 287.59 | 180.42 | |
| b) Fees and Commission Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| c) Net Loss on Fair Value Changes | 0.00 | 0.00 | 0.00 | 0.00 | 23.19 | |
| d) Net Loss on Derecognition of Financial Instruments under Amortised Cost Category | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| d) Employee Benefits | 34.62 | 39.55 | 25.80 | 112.83 | 96.52 | |
| f) Depreciation and amortisation expense | 1.31 | 1.10 | 0.85 | 4.62 | 3.37 | |
| g) Other expenses | 18.74 | 16.52 | 18.36 | 67.85 | 92.27 | |
| h) Bad Debts | 171.47 | 0.00 | 0.00 | 171.47 | 0.00 | |
| Total Expenses | 380.44 | 96.63 | 95.57 | 644.36 | 395.77 | |
| 3 | Profit before exceptional item and tax (1-2) | 201.31 | 40.61 | 31.54 | 291.69 | 183.48 |
| 4 | Exceptional item | 12.01 | 12.01 | 12.02 | 48.06 | 48.06 |
| 5 | Profit before tax (3-4) | 189.29 | 28.60 | 19.52 | 243.62 | 135.42 |
| 6 | Tax expense | 43.00 | 0.00 | 11.11 | 43.00 | 27.61 |
| 7 | Net profit for the period from continuing operations (5-6) | 146.29 | 28.60 | 8.41 | 200.62 | 107.81 |
| 8 | Profit / (Loss) from discontinued operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 9 | Tax expense from discontinued operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 10 | Profit / (Loss) from discontinued operations (After Tax) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 11 | Profit / (Loss) for the period (7+8) | 146.29 | 28.60 | 8.41 | 200.62 | 107.81 |
| 12 | Other comprehensive income, net of income tax | |||||
| (a) (i) Items that will not be reclassified to profit or Loss – Remeasurement of Investment in Shares | -175.08 | -40.81 | -330.27 | -218.95 | -240.61 | |
| (ii) Income Tax relating to items that will not be reclassified to profit or Loss | 45.52 | 10.61 | 85.87 | 56.93 | 62.56 | |
| Subtotal (A) | -129.57 | -30.20 | -244.40 | -162.03 | -178.05 | |
| (b) (i) Items that will be reclassified to profit or Loss | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| (ii) Income Tax relating to items that will not be reclassified to profit or Loss | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Subtotal (B) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other comprehensive income (A+B) | -129.57 | -30.20 | -244.40 | -162.03 | -178.05 | |
| Total Comprehensive Income for the period (11+12) (Comprising Profit (Loss) and other Comprehensive Income for the period) | 16.72 | -1.60 | -235.99 | 38.59 | -70.24 | |
| 13 | Earning per equity share (for continuing operation) | |||||
| – Basic | 1.58 | 0.31 | 0.09 | 2.16 | 1.16 | |
| – Diluted | 1.58 | 0.31 | 0.09 | 2.16 | 1.16 |
Balance Sheet as at March 31, 2026 (standalone)
| Notes | As at March 31, 2026 | As at March 31, 2025 | |
|---|---|---|---|
| ASSETS | |||
| Financial Assets | |||
| Cash and cash equivalents | 3 | 11.36 | 7.59 |
| Loans | 4 | 2,492.96 | 2,698.25 |
| Investments | 5 | 195.59 | 934.38 |
| Other financial assets | 6 | 129.43 | 81.73 |
| Total financial assets | 2,829.33 | 3,721.96 | |
| Non-Financial Assets | |||
| Deferred tax asset (Net) | 7 | 68.57 | 11.64 |
| Property, plant and equipment | 8 | 11.23 | 15.22 |
| Other non-financial assets | 9 | 540.61 | 612.91 |
| Total non-financial Assets | 620.41 | 639.78 | |
| Total Assets | 3,449.74 | 4,361.73 | |
| LIABILITIES AND EQUITY | |||
| Financial Liabilities | |||
| Borrowings (Other than Debt Securities) | 10 | 1,107.24 | 2,027.05 |
| Other financial liabilities | 11 | 18.13 | 7.99 |
| Total Financial Liabilities | 1,125.36 | 2,035.04 | |
| Non-Financial Liabilities | |||
| Deferred tax liability (Net) | 7 | ||
| Current tax liabilities (Net) | 27.23 | 21.85 | |
| Total Non-Financial Liabilities | 27.23 | 21.85 | |
| Total liabilities | 1,152.60 | 2,056.89 | |
| EQUITY | |||
| Equity Share capital | 12 | 925.83 | 925.83 |
| Other Equity | 13 | 1,371.31 | 1,379.01 |
| Total Equity | 2,297.14 | 2,304.84 | |
| Total Liabilities and Equity | 3,449.73 | 4,361.73 |
Statement of cash flows for the year ended March 31, 2026
| Particulars | For the year ended March 31, 2026 | For the year ended March 31, 2025 |
|---|---|---|
| CASH FLOW FROM OPERATING ACTIVITIES | ||
| Net Profit before Taxation | 243.62 | 135.42 |
| Add / Less : Non cash & Non – operating items | ||
| Depreciation and amortisation expense | 4.62 | 3.37 |
| Interest Paid | 287.59 | 180.42 |
| Bad Debts | 171.47 | – |
| Deferred Depreciation | 48.06 | 48.06 |
| (Profit) / Loss on Sale of Investments | -476.83 | -208.05 |
| Net gain / loss in fair value of derivative financial instruments | -46.05 | 23.19 |
| Operating profit before working capital changes | 232.48 | 182.41 |
| Change in operating assets and liabilities | ||
| Loans | -422.82 | 853.39 |
| Other financial assets | 47.69 | 20.22 |
| Other financial liabilities | -10.14 | 23.51 |
| Other non-financial assets | -120.37 | -93.75 |
| Cash used in operations | -273.15 | 985.79 |
| Income taxes paid (net of refunds) | -19.26 | – |
| NET CASH USED IN OPERATING ACTIVITIES (A) | -253.89 | 985.79 |
| CASH FLOW FROM INVESTING ACTIVITIES | ||
| Purchase of property, plant and equipment and intangible assets | 0.63 | – |
| (Increase)/ decrease in Financials Assets Investments | -996.66 | -436.28 |
| NET CASH GENERATED FROM / (USED IN) INVESTING ACTIVITIES [B] | -996.04 | -436.28 |
| CASH FLOW FROM FINANCING ACTIVITIES | ||
| Repayment / (Proceeds) from borrowings (other than debt securities) | 1,207.41 | -586.46 |
| Dividend Paid | 46.29 | 27.77 |
| NET CASH GENERATED FROM / (USED IN) FINANCING ACTIVITIES [C] | 1,253.70 | -558.68 |
| Net decrease in cash and cash equivalents (A+B+C) | 3.76 | -9.18 |
| Cash and cash equivalents at the beginning of the financial year | 7.59 | 16.76 |
| Cash and cash equivalents at end of the year | 11.35 | 7.59 |
Key Audit Matters table (auditor’s report)
| Key Audit Matters | How the matter was addressed in our audit |
|---|---|
| Impairment of financial assets as on 31/03/2026 (Expected Credit Loss) (Refer note 4 of the financial statements) Ind AS 109 relating to “Financial Instruments” requires the company to provide for impairment of its financial assets using the expected credit loss (ECL) approach. The Company has recognized impairment loss allowance of Rs. 66.82 lakhs as at 31 March 2026. This involves management’s judgement in the calculation of impairment allowance which has a significant impact on the financial statements. Management is required to determine the expected credit loss that may occur over either a 12-month period or the remaining life of an asset, depending on the categorisation of the individual asset. The key areas of judgement include: 1. Categorisation of loans in Stage 1, 2 and 3 based on identification of: (a) exposures with significant increase in credit risk (‘SICR’) since their origination (b) Individually impaired / default exposures and (c) Valuation of the property provided as security 2. Determination of Loss Given Default (‘LGD’) and Probability of Default (‘PD’) to calculate ECL based on standard value as adopted. 3. The impact of different future macroeconomic conditions in the determination of ECL. These judgements required the models to be reassessed including the impact of Covid-19 pandemic to measure the ECL. The extent to which the COVID-19 pandemic will impact the Company’s current estimate of impairment loss allowances is dependent on future developments, which are highly uncertain at this point. Given the size of loan portfolio relative to the balance sheet and the impact of impairment allowance on the financial statements, we have considered this as a key audit matter. | Our audit procedures included the following: Read and assessed the company’s accounting policies for impairment of financial assets and their compliance with Ind AS 109. 1. Assessed the approach of the Company for categorisation of loans into various stages. Tested a sample of performing (stage 1) assets to assess whether any SICR or loss indicators were present requiring them to be classified under stage 2 or 3. 2. Analysed the valuation reports of the property secured against the loans with respect to categorisation of loans. 3. Engaged our team to review management’s approach for calculating ECL and assess the key assumptions i.e., probability of default (PD) and loss given default (LGD) used to determine ECL. 4. Performing test of details over calculation of ECL for assessing the correctness of the same. 5. Assessed the progress in settlement with the financial creditors of the associate company, assessed the reason for qualification by the previous auditor and availability of option for liquidity of its investments in the open market. 6. Assessed whether the disclosures on key judgements, assumptions and quantitative data with respect to impairment loss allowance in the financial statements are appropriate and sufficient. As a result of the above audit procedure, no material differences were noted. |